Eppendorf Officially Names New CEO
Mr. Bachmann’s previous positions also include CEO of Tecan (see IBO 2/15/12). In 2014, Eppendorf revenues increased 5.7% to €531.1 million ($708.1 million = €0.75 = $1).
Hamburg, Germany 8/3/15—Life science company Eppendorf has named Thomas Bachmann as CEO (see IBO 2/15/15), effective August 1. Previously, he served as president of Bruker BioSpin (see IBO 9/30/13) and has been a member of Eppendorf’s Supervisory Board since 2013. “He has demonstrated his expertise and his strategic foresight in many ways during more than 25 years of experience in international management positions,” commented Klaus Fink, chairman of the Eppendorf Supervisory Board.
< Previous Article | Next Article >